Niva Bupa Health Insurance reported a strong performance for the financial year ended March 31, 2026. The company achieved a 27.4% overall growth with a GWP of INR 9,433 crore. Annual profit after tax surged by 80% to INR 366 crore, while the return on net worth reached 10.7%. Management continues to leverage a multichannel distribution strategy, technological advancements in AI, and increased hospital empanelment to drive sustainable, long-term growth.
Financial Performance Highlights
Niva Bupa concluded FY’26 on a high note, recording a robust overall growth rate of 27.4% and a Gross Written Premium (GWP) of INR 9,433 crore. Retail health business experienced significant momentum, growing by 35% for the full year. The company’s bottom line showed exceptional improvement, with profit after tax rising to INR 366 crore, compared to INR 203 crore in the previous financial year. The ROE also crossed the double-digit threshold, settling at 10.7%.
Strategic Growth Levers
Management attributes the consistent growth to a highly effective multichannel distribution architecture. During the year, the company successfully added 58,000 agents, over 50 brokers, and partnered with 23 additional financial institutions. The company’s Bharat strategy, which focuses on expanding into Tier 3 cities and beyond, has been a key driver in capturing new customer segments. Additionally, the adoption of modern technologies, including Generative AI and advanced analytics, continues to optimize the entire value chain.
Operational Excellence and Market Share
Niva Bupa’s market share in the retail health segment climbed to 10.1% for the full year, reaching 10.4% in Q4 alone. Operational efficiency improved significantly, with the Combined Ratio under IFRS improving by 160 basis points to 101.4%. The Expense of Management (EOM) ratio also saw a marked improvement, moving to 33.7% from 39.2% in the previous year, supported by operating leverage and economies of scale.
Focus on Healthcare Standardization
The company continues to lead industry initiatives to improve transparency and affordability in healthcare. The common empanelment initiative has now reached 2,500 hospitals, and the company has implemented standard treatment protocols for various infections and medical procedures. These efforts are designed to ensure standardized care pathways, better claims management, and reduced variability in treatment costs, ultimately providing a better experience for the insured population.
Source: BSE
